CLEC-2-dependent activation of mouse platelets is weakly inhibited by cAMP but not by cGMP

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 4, 2014, Pages 550-559

  Borgognone, A ^a,b   Navarro Nunez L ^a   Correia, J N ^a   Pollitt, A Y ^a   Thomas, S G ^a   Eble, J A ^c   Pulcinelli, F M ^b   Madhani, M ^a   Watson, S P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Blood platelets; C type lectin; Cyclic nucleotides; Lymphangiogenesis; Platelet activation

Indexed keywords

C TYPE LECTIN RECEPTOR 2; CELL PROTEIN; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; FIBRINOGEN RECEPTOR; FORSKOLIN; LECTIN RECEPTOR; NITRIC OXIDE; PADGEM PROTEIN; PODOPLANIN; PROSTACYCLIN; RAC PROTEIN; RECOMBINANT PODOPLANIN; RECOMBINANT PROTEIN; THROMBOCYTE ENZYME; THROMBOXANE A2; UNCLASSIFIED DRUG; CALCIUM; CLEC-2 PROTEIN, MOUSE; GP38 PROTEIN, MOUSE; LECTIN; MEMBRANE PROTEIN; RHODOCYTIN PROTEIN, CALLOSELASMA RHODOSTOMA; VIPER VENOM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL ADHESION; CYTOLOGY; DRUG EFFECTS; METABOLISM; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CALCIUM; CELL ADHESION; CYCLIC AMP; CYCLIC GMP; EPOPROSTENOL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NITRIC OXIDE; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; VIPER VENOMS;

EID: 84898041030     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12514     Document Type: Article

References (28)

1. Severin S, Pollitt AY, Navarro-Nunez L, Nash CA, Mourao-Sa D, Eble JA, Senis YA, Watson SP. Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling. J Biol Chem 2011; 286: 4107-16.
2. Watson SP, Herbert JM, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 2010; 8: 1456-67.
3. Suzuki-Inoue K, Inoue O, Ding G, Nishimura S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K, Shin Y, Hirashima M, Ozaki Y. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 2010; 285: 24494-507.
4. Bertozzi CC, Schmaier AA, Mericko P, Hess PR, Zou Z, Chen M, Chen CY, Xu B, Lu MM, Zhou D, Sebzda E, Santore MT, Merianos DJ, Stadtfeld M, Flake AW, Graf T, Skoda R, Maltzman JS, Koretzky GA, Kahn ML. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 2010; 116: 661-70.
5. Finney BA, Schweighoffer E, Navarro-Nunez L, Benezech C, Barone F, Hughes CE, Langan SA, Lowe KL, Pollitt AY, Mourao-Sa D, Sheardown S, Nash GB, Smithers N, Reis e Sousa C, Tybulewicz VL, Watson SP. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood 2012; 119: 1747-56.
6. Osada M, Inoue O, Ding G, Shirai T, Ichise H, Hirayama K, Takano K, Yatomi Y, Hirashima M, Fujii H, Suzuki-Inoue K, Ozaki Y. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem 2012; 287: 22241-52.
7. Ichise H, Ichise T, Ohtani O, Yoshida N. Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development 2009; 136: 191-5.
8. Herzog BH, Fu J, Wilson SJ, Hess PR, Sen A, McDaniel JM, Pan Y, Sheng M, Yago T, Silasi-Mansat R, McGee S, May F, Nieswandt B, Morris AJ, Lupu F, Coughlin SR, McEver RP, Chen H, Kahn ML, Xia L. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 2013; 502: 105-9.
9. Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001; 62: 1153-61.
10. Mannheimer E, Sinzinger H, Oppolzer R, Silberbauer K. Prostacyclin synthesis in human lymphatics. Lymphology 1980; 13: 44-6.
11. Oguogho A, Aghajanian AA, Sinzinger H. Prostaglandin synthesis in human lymphatics from precursor fatty acids. Lymphology 2000; 33: 62-6.
12. Leak LV, Cadet JL, Griffin CP, Richardson K. Nitric oxide production by lymphatic endothelial cells in vitro. Biochem Biophys Res Commun 1995; 217: 96-105.
13. Mizuno R, Koller A, Kaley G. Regulation of the vasomotor activity of lymph microvessels by nitric oxide and prostaglandins. Am J Physiol 1998; 274: R790-6.
14. Rehal S, Blanckaert P, Roizes S, von der Weid PY. Characterization of biosynthesis and modes of action of prostaglandin E2 and prostacyclin in guinea pig mesenteric lymphatic vessels. Br J Pharmacol 2009; 158: 1961-70.
15. Smolenski A. Novel roles of cAMP/cGMP-dependent signaling in platelets. J Thromb Haemost 2012; 10: 167-76.
16. Eble JA, Beermann B, Hinz HJ, Schmidt-Hederich A. alpha 2 beta 1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J Biol Chem 2001; 276: 12274-84.
17. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005; 166: 913-21.
18. Hughes CE, Pollitt AY, Mori J, Eble JA, Tomlinson MG, Hartwig JH, O'Callaghan CA, Futterer K, Watson SP. CLEC-2 activates Syk through dimerization. Blood 2010; 115: 2947-55.
19. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
20. Pollitt AY, Grygielska B, Leblond B, Desire L, Eble JA, Watson SP. Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac. Blood 2010; 115: 2938-46.
21. Kato Y, Fujita N, Kunita A, Sato S, Kaneko M, Osawa M, Tsuruo T. Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. J Biol Chem 2003; 278: 51599-605.
22. Suzuki-Inoue K, Kato Y, Inoue O, Kaneko MK, Mishima K, Yatomi Y, Yamazaki Y, Narimatsu H, Ozaki Y. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem 2007; 282: 25993-6001.
23. Mukherjee S, Zhu J, Zikherman J, Parameswaran R, Kadlecek TA, Wang Q, Au-Yeung B, Ploegh H, Kuriyan J, Das J, Weiss A. Monovalent and multivalent ligation of the B cell receptor exhibit differential dependence upon Syk and Src family kinases. Sci Signal 2013; 6: ra1. 10.1126/scisignal.2003220
24. McCarty OJ, Larson MK, Auger JM, Kalia N, Atkinson BT, Pearce AC, Ruf S, Henderson RB, Tybulewicz VL, Machesky LM, Watson SP. Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J Biol Chem 2005; 280: 39474-84.
25. Gegenbauer K, Elia G, Blanco-Fernandez A, Smolenski A. Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets. Blood 2012; 119: 3799-807.
26. Emambokus NR, Frampton J. The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis. Immunity 2003; 19: 33-45.
27. Lowe KL, Navarro-Nunez L, Watson SP. Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb Res 2012; 129(Suppl 1): S30-7.
28. Bazou D, Santos-Martinez MJ, Medina C, Radomski MW. Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap. Br J Pharmacol 2011; 162: 1577-89.